Exosomes after needling: size, source, and the vial that has to be sterile

Exosomes are lipid vesicles with a biography, and the biography starts inside the cell. They come out of the endosomal pathway: the cell buds membrane inward, packs proteins, lipids and RNA into intraluminal vesicles, and releases them outside after fusion with the plasma membrane. The size range that serious papers keep repeating sits at about 30 to 150 nanometres. Much larger, and you are quickly looking at a different class of particle. Much smaller, and the analytics get unreliable when light scattering and electron microscopy refuse to agree. A growth-factor ampoule with a newer name is a marketing object. It is a poor description of that pathway.

In professional retail at the Kosmetikfachhandel in Munich, the cellular route has become a cabin product with gloves in the photograph. After microneedling, the sales logic goes, the vesicles dock on the opened barrier and deliver miRNA and proteins into skin. Part of the logic is physically coherent. Intact stratum corneum barely lets a 100-nanometre vesicle through. Freshly needled skin is more permeable. It is also a wound. At that moment the universal growth-factor myth stops being the interesting part. Source, sterility and legal identity start being the whole conversation.

Exosome, microvesicle, or a supernatant with good type

The International Society for Extracellular Vesicles separates exosomes from microvesicles, which bud directly off the cell surface and are often larger, and from apoptotic bodies, which appear when cells die and can carry debris. Cosmetic and aesthetic products at fairs are often labelled exosomes across the board, even when the lot is a mixture of conditioned medium, vesicles and free protein. Conditioned medium is the liquid cells grew in. Exosomes are a fraction of it, beside cytokines nobody has characterised and nobody has priced honestly.

For a clinic this is the first liability lever, and it is a paperwork lever before it is a biological one. Ask which fraction is in the vial. Was it differentially centrifuged, filtered, separated by chromatography? Is there a size distribution, ideally from more than one method? Does the certificate say extracellular vesicles, or does it say exosomes when only a supernatant was filled? Free growth factors and enclosed miRNA behave differently, store differently, and are read differently by regulators. The difference survives a rebrand.

A vesicle of 30 to 150 nanometres is a defined fraction. A cell supernatant printed with the word exosome stays a claim until size, markers and sterility are on the certificate.

Markers help the sorting when a booth is willing to be boring. Research uses tetraspanins such as CD9, CD63 and CD81 to support exosome enrichment, plus evidence that cellular debris is absent. A booth that cannot name a single marker is selling a word in a cold colour palette. A booth that names markers and withholds a particle count per millilitre is still selling a story, only with better footnotes. Particle count and protein content together tell you whether you are buying vesicles or a protein solution that learned a fashionable noun.

Sterility, because the skin is open

Needling opens the barrier at depths that run from 0.25 millimetres of cosmetic stimulation to several millimetres in medical scar protocols. In every case the skin has stopped being an intact surface. A preparation placed at that moment has to be low in bioburden, and sterile when the work goes deeper. Cosmetic serums from an open pipette bottle that sits out all day fail that test before the first drop. Exosome preparations are biological material. They contaminate readily. They are often lightly preserved, because preservatives disturb the vesicles or disturb the claim, and the claim usually wins the argument inside the company.

The cabin rule is narrow enough to memorise. Only a presentation the maker has released for use on non-intact skin. Single withdrawal. The vial does not wait in the fridge for the next guest. A cold chain, if one is required, comes with a temperature log. A feeling about the fridge is how lots drift. Lot, time of opening and skin response over the next 72 hours go in the chart. Redness that belongs to needling has a shape you already know. Redness that spreads, weeps or hurts is a different event. It stops any repeat and moves to a physician. The clinic recognises the boundary. It does not diagnose an infection in the doorway to stay on schedule.

Plant vesicles, from fruit cell culture or isolated plant exosomes, carry a different safety profile from vesicles of human mesenchymal cells or platelets. Harmless is a conclusion you earn with data. Characterised is the word that matters. Human cell material can fall out of cosmetics quickly in Europe and be read as a medicine or an advanced therapy medicinal product. Applying it in a cosmetic cabin because it stood under cleanroom lighting at a supplier demo carries a classification risk no training video dissolves. The video ends. The statute does not.

• Exosomes typically sit at 30 to 150 nanometres and come from the endosomal pathway.
• Microvesicles and apoptotic bodies are other classes. A supernatant has not yet become any of them because a label said so.
• Markers such as CD9, CD63 and CD81, plus a particle count, separate a fraction from a word on the glass.
• After needling, the released single-use dose applies, sterile where the depth requires it. Open pipette bottles stay in the photograph.
• Human cell material can leave cosmetics. Source and legal status belong in the consent conversation, before the needle, while there is still time to decline.

miRNA, and the myth that skips the measurement

Vesicles can carry microRNA, short RNA pieces that damp translation of certain proteins in a recipient cell. Dermatological research looks at that in fibroblasts, pigment and inflammation, usually with a dose someone bothered to measure. The jump is large between a characterised dose in a model and a vial whose RNA content nobody has assayed. A growth-factor complex is often the vaguer version of the same product: proteins that can push cell division, in an unknown amount, on skin that depending on context may show repair or unwanted proliferation. The myth begins when every vial is sold as universal regeneration, regardless of source and dose, with the same sentence for a scar and a dull cheek.

Clinics in Munich offering medical beauty while remaining outside medical practice should run the needling combination only when both parts are classified as cosmetic and the depth stays inside a cosmetic frame. Medical depths, blood and human cell preparations are a different event, with a different room and a different consent form. The menu has to separate them in type large enough to read at reception. A client who expects exosomes like the clinic down the road is told which fraction is used, what it comes from, and what stays off the promise list: tissue on demand, a guarantee on a scar, cellular rejuvenation as a result you can book.

At the festival, the sterile look of the stands is both a test and a set. Cleanroom light, white surfaces, gloves in the photograph. Ask for the manufacturing room, the bioburden limit and the date the particle size of the current lot was measured. A photograph does not replace a certificate. A certificate from two years ago does not replace today’s vial, which may have had a warmer journey than the PDF.

Four sentences before the price goes live

Before exosomes go on the price list, four sentences exist in writing, and a fifth person in the clinic can find them. Classification, cosmetic or otherwise. Source: plant, animal, human, and the country of manufacture. Sterility or the bioburden limit for the intended use. The sentence you are allowed to say to the client, matched to what the analytics support. If one of the four is missing, the preparation stays a supplier topic. It does not become a step between the cleanse and the LED.

The growth-factor myth is convenient because it explains every effect and demands no measurement, which is why it photographs well. Vesicles of 30 to 150 nanometres demand the opposite temperament. They are small enough to be taken seriously and undefined enough to do harm when source and sterility are folklore passed along a stand. Medical beauty in professional retail either grows up at this vial or it becomes exposed the first time a chart is read by someone who cultures things for a living. The client hears what is going into the openings before the needling. Afterward is a story. Beforehand is consent.